Prostate Cancer - Results from #24940

Risk factors for rectal bleeding associated with I-125 brachytherapy for prostate cancer - Abstract September 3, 2012

Does a surgeon's annual radical prostatectomy volume predict the risk of positive surgical margins and urinary incontinence at one-year follow-up? - Findings from a prospective national study - Abstract September 3, 2012

First-in-man application of a novel therapeutic cancer vaccine formulation with the capacity to induce multi-functional T cell responses in ovarian, breast and prostate cancer patients - Abstract September 3, 2012

Evaluation of the deformation and corresponding dosimetric implications in prostate cancer treatment - Abstract September 3, 2012

On the beam direction search space in computerized non-coplanar beam angle optimization for IMRT-prostate SBRT - Abstract September 3, 2012

Green and black tea intake in relation to prostate cancer risk among Singapore Chinese - Abstract September 3, 2012

Sipuleucel-T immune parameters correlate with survival: An analysis of the randomized phase 3 clinical trials in men with castration-resistant prostate cancer - Abstract September 3, 2012

Molecular diagnostic tools for the detection of nodal micrometastases in prostate cancer patients undergoing radical prostatectomy with extended pelvic lymph node dissection: A prospective study - Abstract September 3, 2012

Anatomically versus biologically unifocal prostate cancer: A pathological evaluation in the context of focal therapy - Abstract September 1, 2012

Abiraterone and other novel androgen-directed strategies for the treatment of prostate cancer: A new era of hormonal therapies is born - Abstract September 1, 2012

Inflammation and prostate carcinogenesis - Abstract September 1, 2012

The role of the maximum involvement of biopsy core in predicting outcome for patients treated with dose-escalated radiation therapy for prostate cancer - Abstract September 1, 2012

Impact of pre-implant lower urinary tract symptoms on postoperative urinary morbidity after permanent prostate brachytherapy - Abstract September 1, 2012

FDA approves Xtandi (enzalutamide) September 1, 2012

Long term results of a prospective dose escalation phase-II trial: Interstitial pulsed-dose-rate brachytherapy as boost for intermediate- and high-risk prostate cancer - Abstract August 31, 2012

A novel measure of dietary change in a prostate cancer dietary program incorporating mindfulness training - Abstract August 31, 2012

Evaluation of physician eye lens doses during permanent seed implant brachytherapy for prostate cancer - Abstract August 31, 2012

Practice patterns in the management of prostate cancer in Spain: Results from a national survey among radiation oncologists in 2009 - Abstract August 31, 2012

Evaluation of the association of prostate cancer-specific anxiety with sexual function, depression and cancer aggressiveness in men 1 year following surgical treatment for localized prostate cancer - Abstract August 31, 2012

Effect of prostate-specific antigen screening on metastatic disease burden 10 years after diagnosis - Abstract August 31, 2012

Page 1248 of 1437